Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn's Disease

Gianluca Galazzo, Danyta I. Tedjo, Dion S. J. Wintjens, Paul H. M. Savelkoul, Ad A. M. Masclee, Alexander G. L. Bodelier, Marie J. Pierik, Daisy M. A. E. Jonkers, John Penders*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: Microbial shifts have been associated with disease activity in Crohn's disease [CD], but findings on specific taxa are inconsistent. This may be due to differences in applied methods and cross-sectional study designs. We prospectively examined the faecal microbiota in adult CD patients with changing or stable disease course over time.

Methods: Faeces were collected at two time-points from 15 healthy control individuals [HCs], 35 CD patients who were in remission and who maintained remission [RRs], and 22 CD patients during remission and also during subsequent exacerbation [RAs]. The microbial composition was assessed by 16S rRNA [V4] gene sequencing.

Results: Compared with HCs, patients with CD had a lower microbial richness [p = 0.0002] and diversity [p = 0.005]. Moreover, the microbial community structure of a subset of patients, clustered apart from HCs, was characterized by low microbial diversity and Faecalibacterium abundance. Patients within this cluster did not differ with respect to long-term disease course compared with patients with a `healthy-appearing' microbiota. Over time, microbial richness and diversity did not change in RR versus RA patients. Although the microbial community structure of both RR and RA patients was less stable over time compared with that of HCs, no differences were observed between the patient groups [p = 0.17]; nor was the stability impacted by Montreal classification, medication use, or surgery.

Conclusion: The altered microbiota composition and stability in CD was neither associated with disease activity nor long-term disease course, questioning its involvement in the development of an exacerbation. The aberrant microbiota composition in a subset of CD patients warrants further exploration of a more microbiota-driven etiology in this group.

Original languageEnglish
Pages (from-to)1273-1282
Number of pages10
JournalJournal of Crohn's & Colitis
Volume13
Issue number10
DOIs
Publication statusPublished - Oct 2019

Keywords

  • Crohn's disease
  • microbiota
  • disease course
  • 16S rRNA gene
  • microbiota dynamics
  • INFLAMMATORY-BOWEL-DISEASE
  • GUT MICROBIOTA
  • FAECALIBACTERIUM-PRAUSNITZII
  • CLINICAL INDEXES
  • PROFILES
  • COLITIS
  • MARKER
  • TIME

Cite this